Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 20, 2022

SELL
$82.37 - $107.29 $53,293 - $69,416
-647 Reduced 2.89%
21,709 $1.79 Million
Q2 2022

Jul 19, 2022

SELL
$86.5 - $128.27 $249,985 - $370,700
-2,890 Reduced 11.45%
22,356 $2.13 Million
Q1 2022

May 25, 2022

SELL
$101.96 - $128.34 $37,113 - $46,715
-364 Reduced 1.42%
25,246 $2.97 Million
Q4 2021

Jan 25, 2022

SELL
$106.37 - $130.68 $67,651 - $83,112
-636 Reduced 2.42%
25,610 $3.32 Million
Q3 2021

Oct 14, 2021

BUY
$102.91 - $122.75 $2.7 Million - $3.22 Million
26,246 New
26,246 $2.97 Million
Q2 2021

Jul 20, 2021

SELL
$83.84 - $104.76 $2.25 Million - $2.81 Million
-26,860 Closed
0 $0
Q1 2021

Apr 16, 2021

BUY
$78.68 - $90.67 $247,448 - $285,157
3,145 Added 13.26%
26,860 $2.25 Million
Q4 2020

Jan 19, 2021

BUY
$71.69 - $91.23 $2,365 - $3,010
33 Added 0.14%
23,715 $2.16 Million
Q3 2020

Oct 29, 2020

SELL
$67.19 - $87.44 $21,903 - $28,505
-326 Reduced 1.36%
23,682 $1.89 Million
Q2 2020

Jul 20, 2020

BUY
$57.54 - $76.95 $846,873 - $1.13 Million
14,718 Added 158.43%
24,008 $1.66 Million
Q1 2020

Apr 16, 2020

SELL
$52.41 - $81.0 $150,835 - $233,118
-2,878 Reduced 23.65%
9,290 $1.75 Million
Q4 2019

Jan 14, 2020

SELL
$71.7 - $82.09 $18,785 - $21,507
-262 Reduced 2.11%
12,168 $946,000
Q3 2019

Oct 15, 2019

SELL
$61.55 - $75.43 $2,031 - $2,489
-33 Reduced 0.26%
12,430 $2.73 Million
Q2 2019

Jul 19, 2019

SELL
$55.74 - $64.41 $25,417 - $29,370
-456 Reduced 3.53%
12,463 $2.3 Million
Q1 2019

May 15, 2019

BUY
$47.89 - $64.05 $35,151 - $47,012
734 Added 6.02%
12,919 $2.47 Million
Q4 2018

Feb 14, 2019

BUY
$46.41 - $56.94 $565,505 - $693,813
12,185 New
12,185 $1.87 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Genesee Capital Advisors, LLC Portfolio

Follow Genesee Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Genesee Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Genesee Capital Advisors, LLC with notifications on news.